Sign Up
OverviewAPI
Zoetis Inc. agrees to sell its medicated feed additive portfolio to Phibro Animal Health for $350 million, with the portfolio generating $400 million in revenue in 2023. The transaction includes over 37 product lines sold in 80 countries and involves six manufacturing sites across the U.S., Italy, and China.

Ask a question